Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT.

Photodynamic therapy (PDT) has been used for many years, but it is only now becoming widely accepted and utilized. Originally it was developed as a tumor therapy and some of its most successful applications are for non-malignant diseases. This article provides a broad review of different parameters used and mechanisms instituted in PDT such as photosensitizers (PS), photochemistry and photophysics, cellular localization, cellular signaling, cell metabolism and modes of cell death that operate on a cellular level, as well as photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. These specific cellular mechanisms are most commonly applied in PDT and for the most part are often researched and exploited. If the combination of these specific parameters and mechanisms can be optimized within PDT it could possibly be used as a suitable alternative for the treatment and management of specific cancers.

[1]  P. Speight,et al.  Induction of apoptotic cell death by photodynamic therapy in human keratinocytes. , 1998, Archives of oral biology.

[2]  Yan Jin,et al.  Reconstruction of a tissue‐engineered skin containing melanocytes , 2007, Cell biology international.

[3]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.

[4]  C. Sibata,et al.  Clinical photodynamic therapy of head and neck cancers-A review of applications and outcomes. , 2005, Photodiagnosis and photodynamic therapy.

[5]  M. Adamek,et al.  Photodynamic diagnosis (PDD) and photodynamic therapy (PDT) in dermatology: "How we do it". , 2006, Photodiagnosis and photodynamic therapy.

[6]  C. Roland,et al.  ICAM-1 expression determines malignant potential of cancer. , 2007, Surgery.

[7]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.

[8]  J. Moan,et al.  The history of PDT in Norway Part one: Identification of basic mechanisms of general PDT. , 2007, Photodiagnosis and photodynamic therapy.

[9]  J. Moan,et al.  The history of PDT in Norway Part II. Recent advances in general PDT and ALA-PDT. , 2007, Photodiagnosis and photodynamic therapy.

[10]  M. Alexiades-Armenakas.  Laser-mediated photodynamic therapy. , 2006, Clinics in dermatology.

[11]  D. Nowis,et al.  The influence of photodynamic therapy on the immune response. , 2005, Photodiagnosis and photodynamic therapy.

[12]  M. C. Pazos,et al.  Effect of photodynamic therapy on the extracellular matrix and associated components. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[13]  S. Xiao,et al.  Apoptotic effect and mechanisms of AHPN on human skin malignant melanoma cell A375 , 2008 .

[14]  B. Thiers,et al.  The Gene Expression Signatures of Melanoma Progression , 2006 .

[15]  F. Berr,et al.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.

[16]  J. Bansard,et al.  Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy , 2006, Journal of Neuro-Oncology.

[17]  C. Acher,et al.  How We do it , 1999 .

[18]  M. Maccormack,et al.  Photodynamic therapy in dermatology: an update on applications and outcomes. , 2008, Seminars in cutaneous medicine and surgery.

[19]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.

[20]  M. Bentley,et al.  Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.

[21]  J. Marshall,et al.  Skin cancer models , 2005 .

[22]  L. Davids,et al.  Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. , 2008, Journal of photochemistry and photobiology. B, Biology.

[23]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[24]  M. Castagnola,et al.  Comparison between three molecular methods for detection of blood melanoma tyrosinase mRNA. Correlation with melanoma stages and S100B, LDH, NSE biochemical markers. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[25]  G. Stables,et al.  Topical photodynamic therapy for non-cancerous skin conditions. , 2006, Photodiagnosis and photodynamic therapy.

[26]  L. Puskás,et al.  Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies. , 2006, Cellular immunology.

[27]  P Baas,et al.  Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[28]  T. Lotti,et al.  Photodynamic therapy: off-label and alternative use in dermatological practice. , 2008, Photodiagnosis and photodynamic therapy.

[29]  M. Ochsner.  Light scattering of human skin: a comparison between zinc (II)-phthalocyanine and photofrin II. , 1996, Journal of photochemistry and photobiology. B, Biology.

[30]  Patrizia Agostinis,et al.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.

[31]  Kevin D Cooper,et al.  Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. , 2007, Toxicology and applied pharmacology.

[32]  Yen‐Hua Huang,et al.  Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes. , 2008, Journal of dermatological science.

[33]  A. Kübler.  Photodynamic therapyPhotodynamische Therapie , 2005 .